RESULTS
Our sample included 3874 persons with diabetes, representing 114,710,140 US adults. There were several sociodemographic and clinical differences between the racial/ethnic groups examined (Table 1) Despite there being no statistically significant changes in the prevalence of reduced kidney function for any racial/ethnic group over the period examined, we observed opposite, although statistically insignificant, trends in the prevalence of reduced kidney function among NHWs (with increasing prevalence) and NHBs (with decreasing prevalence) (P ¼ 0.06 for both). Thus 
DISCUSSION
We found that the overall prevalence of DKD (defined by reduced kidney function or albuminuria) among each of the 3 racial/ethnic groups examined remained Data are expressed in weighted means AE SD and proportions AE SD. BMI, body mass index; BP, blood pressure; eGFR, estimated glomerular filtration rate; NHANES, National Health and Nutrition Examination Survey; obs, observations; Urine ACR, urine albumin to creatinine ratio.
similar during most of the past decade, which is consistent with previous studies reporting the prevalence of DKD in the US population overall. 6, 7 Our study extends these studies by noting that disparities in DKD prevalence comparing NHB and Hispanic individuals with NHWs have persisted over the past decade. Notably, however, at different time points through the decade examined, there were some declining trends in the NHB versus NHW disparity in reduced kidney function. This finding should be considered in the context of previous reports of increasing prevalence of reduced kidney function in the general US population of persons with diabetes, 6, 7 which may have been due to increasing prevalence among NHWs.
A key limitation of our study was the lack of sufficient data in the National Health and Nutrition Examination Survey to allow for analyses of other racial/ ethnic groups, such as American Indian and Asian individuals. Similarly, we were not able to examine subpopulations of Hispanic individuals, which may share genetic and social risks similar to NHBs (e.g., black Hispanic individuals).
The underlying reasons for the persistence of racial/ ethnic disparities in DKD are likely multifactorial, to include constitutional factors (e.g., genetic background), health behaviors (e.g., dietary patterns) and socially determined factors (e.g., access to highquality health care). Further exploration of these findings could identify opportunities to narrow disparities in DKD prevalence. Strategies that have proven successful in decreasing rates of end-stage kidney disease among minority populations with diabetes include the program of the Indian Health Service and the Centers for Disease Control and Prevention, which used a population health approach to treating kidney disease, in the context of routine diabetes care. 8 Whether such approaches could improve DKD outcomes among other racial/ethnic minority groups, such as NHB and Hispanic individuals, should be explored. Race/ethnicity trends in chronic kidney disease among US adults with diabetes. The prevalence of reduced eGFR adjusted for age and sex (a), the prevalence of albuminuria adjusted for age and sex (b), and the prevalence of reduced eGFR or albuminuria adjusted for age and sex (c). eGFR, estimated glomerular filtration rate; UAC ratio, urine albumin-to-creatinine ratio.
